We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

RaNA Therapeutics Acquires Shire's Leading mRNA Therapy Platform.

News   Jan 05, 2017 | Original Story From RaNA Therapeutics

 
RaNA Therapeutics Acquires Shire's Leading mRNA Therapy Platform.
 
 
Advertisement
 

RELATED ARTICLES

Machine Learning Method Predicts Cell Fate

News

Scientists have created a machine learning method and open source software to estimate the dynamics of gene activity in single cells, allowing biologists to robustly predict the future state of individual cells.

READ MORE

Four-Stranded DNA Plays a Role in Certain Types of Breast Cancer

News

Four stranded DNA structures called G-quadruplexes have been shown to play a role in certain types of breast cancer, providing a potential new therapeutic target.

READ MORE

Neural Progenitor Cells Discovered in the Optic Nerve

News

Researchers at the University of Maryland School of Medicine have for the first time identified stem cells in the region of the optic nerve, which transmits signals from the eye to the brain. The finding presents a new theory on why the most common form of glaucoma may develop and provides potential new ways to treat a leading cause of blindness in American adults.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE